Skip to main content
Clinical Trials/IRCT20170513033941N69
IRCT20170513033941N69
Recruiting
Phase 3

Comparing the effects of N-acetylcysteine administration and placebo on clinical status and metabolic profiles in overweight or obese women with fibrocystic changes of breast

Kashan University of Medical Sciences0 sites74 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Breast fibrocystic disease.
Sponsor
Kashan University of Medical Sciences
Enrollment
74
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18\-45 years
  • women diagnosed with fibrocystic breast disease
  • having moderate or severe cyclic mastalgia

Exclusion Criteria

  • Malignant breast diseases
  • Taking medicines for reducing pain (such as danazol, tamoxifen, bromocriptine) over the past three months
  • Menopause women
  • Pregnant or breastfeeding women
  • Psychological diseases
  • Unwillingness to cooperate

Outcomes

Primary Outcomes

Not specified

Similar Trials